Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of PFKFB4 mRNA | CTD | PMID:23649840 | 1,1-dichloroethene | increases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:26682919 | 1,2-dichloroethane | increases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of PFKFB4 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PFKFB4 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PFKFB4 mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of PFKFB4 mRNA | CTD | PMID:30723492 | 17beta-estradiol | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of PFKFB4 mRNA and [Estradiol co-treated with TGFB1 protein] results in increased expression of PFKFB4 mRNA | CTD | PMID:22217510 and PMID:30165855 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of PFKFB4 mRNA | CTD | PMID:26496021 | 17beta-estradiol | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of PFKFB4 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3',4,4',5-Pentachlorobiphenyl | decreases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PFKFB4 mRNA | CTD | PMID:21724226 and PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PFKFB4 mRNA | CTD | PMID:33387578 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-methylcholine | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of PFKFB4 mRNA | CTD | PMID:21179406 | 4,4'-sulfonyldiphenol | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of PFKFB4 mRNA | CTD | PMID:27685785 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Pfkfb4 (Mus musculus) | 6480464 | bisphenol S affects the methylation of PFKFB4 gene | CTD | PMID:31683443 | 5-aza-2'-deoxycytidine | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Decitabine affects the expression of PFKFB4 mRNA | CTD | PMID:23300844 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of PFKFB4 mRNA | CTD | PMID:24780913 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PFKFB4 mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of PFKFB4 mRNA | CTD | PMID:33212167 | arsane | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PFKFB4 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PFKFB4 mRNA | CTD | PMID:32525701 | arsenous acid | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PFKFB4 mRNA | CTD | PMID:27829220 | aspartame | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [Fats more ... | CTD | PMID:23783067 | benzo[a]pyrene | increases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PFKFB4 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | PFKFB4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of PFKFB4 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of PFKFB4 mRNA | CTD | PMID:21632981 | benzo[e]pyrene | decreases methylation | ISO | PFKFB4 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of PFKFB4 polyA tail | CTD | PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PFKFB4 mRNA | CTD | PMID:17010207 | bisphenol A | increases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | bisphenol A results in increased expression of PFKFB4 mRNA | CTD | PMID:34585602 | bisphenol A | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | bisphenol A affects the expression of PFKFB4 mRNA | CTD | PMID:30903817 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of PFKFB4 gene | CTD | PMID:28505145 | bisphenol A | increases methylation | ISO | Pfkfb4 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of PFKFB4 promoter | CTD | PMID:27312807 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PFKFB4 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of PFKFB4 mRNA | CTD | PMID:26496021 | butan-1-ol | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PFKFB4 mRNA | CTD | PMID:29432896 | cadmium dichloride | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:25596134 | carbamazepine | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of PFKFB4 mRNA | CTD | PMID:25979313 | chloroacetaldehyde | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | chloroacetaldehyde results in increased expression of PFKFB4 mRNA | CTD | PMID:25596134 | chloropicrin | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | chloropicrin results in increased expression of PFKFB4 mRNA | CTD | PMID:26352163 | chlorpyrifos | decreases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of PFKFB4 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKFB4 mRNA | CTD | PMID:20938992 | chromium(6+) | affects expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of PFKFB4 mRNA | CTD | PMID:28472532 | cidofovir anhydrous | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Cidofovir affects the expression of PFKFB4 mRNA | CTD | PMID:25596134 | cisplatin | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of PFKFB4 mRNA and Cisplatin results in increased expression of PFKFB4 protein | CTD | PMID:16803524 and PMID:27594783 | cisplatin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of PFKFB4 mRNA | CTD | PMID:25596134 | cisplatin | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Cisplatin affects the expression of PFKFB4 mRNA | CTD | PMID:23300844 | clodronic acid | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Clodronic Acid results in decreased expression of PFKFB4 mRNA | CTD | PMID:25596134 | cobalt atom | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of PFKFB4 mRNA and [tungsten carbide co-treated with Cobalt] results in increased expression of PFKFB4 mRNA | CTD | PMID:18078969 and PMID:20105288 | cobalt dichloride | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [cobaltous chloride results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA and zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB4 mRNA] | CTD | PMID:16025159 and PMID:22202117 | cobalt dichloride | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:20105288 and PMID:22202117 | curcumin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Curcumin results in decreased expression of PFKFB4 mRNA | CTD | PMID:17198877 | cyclosporin A | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of PFKFB4 mRNA | CTD | PMID:20106945 more ... | cyclosporin A | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of PFKFB4 mRNA | CTD | PMID:25596134 | deguelin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | deguelin results in decreased expression of PFKFB4 mRNA | CTD | PMID:33512557 | desferrioxamine B | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Deferoxamine results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA | CTD | PMID:16025159 | dexamethasone | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of PFKFB4 mRNA | CTD | PMID:25047013 | diarsenic trioxide | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of PFKFB4 mRNA | CTD | PMID:27829220 | dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of PFKFB4 mRNA | CTD | PMID:18636392 | dioxygen | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... | CTD | PMID:16025159 and PMID:24403227 | dioxygen | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of PFKFB4 mRNA and Oxygen deficiency results in increased expression of PFKFB4 protein | CTD | PMID:16025159 more ... | doxorubicin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of PFKFB4 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of PFKFB4 mRNA | CTD | PMID:29391264 | ethanol | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PFKFB4 mRNA and [Ethanol co-treated with Folic Acid] results in increased expression of PFKFB4 mRNA | CTD | PMID:23378141 and PMID:29432896 | ethanol | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Ethanol results in increased expression of PFKFB4 mRNA | CTD | PMID:23378141 | ethyl methanesulfonate | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of PFKFB4 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | decreases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PFKFB4 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Ethanol co-treated with Folic Acid] results in increased expression of PFKFB4 mRNA | CTD | PMID:23378141 | formaldehyde | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of PFKFB4 mRNA | CTD | PMID:23649840 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of PFKFB4 mRNA | CTD | PMID:17010207 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of PFKFB4 mRNA | CTD | PMID:33387578 | hydralazine | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PFKFB4 mRNA | CTD | PMID:17183730 | iron atom | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [cobaltous chloride results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA and [Deferoxamine results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA | CTD | PMID:16025159 | iron(0) | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [cobaltous chloride results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA and [Deferoxamine results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA | CTD | PMID:16025159 | isobutanol | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PFKFB4 mRNA | CTD | PMID:29432896 | L-methionine | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PFKFB4 mRNA | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PFKFB4 mRNA | CTD | PMID:35811015 | lipopolysaccharide | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of PFKFB4 mRNA | CTD | PMID:35811015 | maneb | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of PFKFB4 mRNA | CTD | PMID:36117858 | methapyrilene | decreases methylation | ISO | PFKFB4 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of PFKFB4 polyA tail | CTD | PMID:30157460 | methyl methanesulfonate | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of PFKFB4 mRNA | CTD | PMID:23649840 | monosodium L-glutamate | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [Fats more ... | CTD | PMID:23783067 | motexafin gadolinium | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | motexafin gadolinium results in increased expression of PFKFB4 mRNA | CTD | PMID:16357179 | motexafin gadolinium | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PFKFB4 mRNA | CTD | PMID:16357179 | nickel dichloride | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | nickel chloride results in increased expression of PFKFB4 mRNA | CTD | PMID:21455298 | Nonylphenol | increases expression | EXP | | 6480464 | nonylphenol results in increased expression of PFKFB4 mRNA | CTD | PMID:17010207 | oxaliplatin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | oxaliplatin results in decreased expression of PFKFB4 mRNA | CTD | PMID:17762391 | ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of PFKFB4 mRNA | CTD | PMID:18636392 | ozone | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of PFKFB4 mRNA | CTD | PMID:35430440 | ozone | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PFKFB4 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PFKFB4 mRNA | CTD | PMID:17562736 | paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of PFKFB4 mRNA | CTD | PMID:15206577 | paraquat | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of PFKFB4 mRNA | CTD | PMID:36117858 | quercetin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of PFKFB4 mRNA | CTD | PMID:21632981 | rotenone | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of PFKFB4 mRNA | CTD | PMID:33512557 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PFKFB4 mRNA | CTD | PMID:35811015 | sodium arsenate | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PFKFB4 mRNA | CTD | PMID:32525701 | sotorasib | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PFKFB4 mRNA | CTD | PMID:36139627 | sunitinib | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of PFKFB4 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of PFKFB4 mRNA | CTD | PMID:33848595 | testosterone | multiple interactions | ISO | Pfkfb4 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:33848595 | thapsigargin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of PFKFB4 mRNA | CTD | PMID:22378314 | thimerosal | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of PFKFB4 mRNA | CTD | PMID:27188386 | trametinib | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PFKFB4 mRNA | CTD | PMID:36139627 | tributylstannane | increases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | tributyltin results in increased expression of PFKFB4 mRNA | CTD | PMID:31939706 | trichloroethene | affects expression | EXP | | 6480464 | Trichloroethylene affects the expression of PFKFB4 mRNA | CTD | PMID:33387578 | trichostatin A | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | trichostatin A affects the expression of PFKFB4 mRNA | CTD | PMID:28542535 | triclosan | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of PFKFB4 mRNA | CTD | PMID:30510588 | triptonide | decreases expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | triptonide results in decreased expression of PFKFB4 mRNA | CTD | PMID:33045310 | Tungsten carbide | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of PFKFB4 mRNA and [tungsten carbide co-treated with Cobalt] results in increased expression of PFKFB4 mRNA | CTD | PMID:18078969 and PMID:20105288 | tunicamycin | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of PFKFB4 mRNA | CTD | PMID:22378314 | uranium atom | affects expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Uranium affects the expression of PFKFB4 mRNA | CTD | PMID:15672453 | urethane | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Urethane results in increased expression of PFKFB4 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | Pfkfb4 (Mus musculus) | 6480464 | Valproic Acid affects the expression of PFKFB4 mRNA | CTD | PMID:17292431 | valproic acid | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of PFKFB4 mRNA | CTD | PMID:17183730 | vincristine | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of PFKFB4 mRNA | CTD | PMID:23649840 | vorinostat | decreases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of PFKFB4 mRNA | CTD | PMID:27188386 | zinc acetate | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of PFKFB4 mRNA | CTD | PMID:16357179 | zinc acetate | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | Zinc Acetate results in increased expression of PFKFB4 mRNA | CTD | PMID:16357179 | zinc dichloride | multiple interactions | ISO | PFKFB4 (Homo sapiens) | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of PFKFB4 mRNA] | CTD | PMID:22202117 | zoledronic acid | increases expression | ISO | PFKFB4 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of PFKFB4 mRNA | CTD | PMID:24714768 and PMID:25596134 | | |||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Molecular Pathway Annotations Click to see Annotation Detail View
